The Molecular Targets of Antitumor 2-deoxycytidine Analogues
Journal:
Current Drug Targets
Volume:
4
Page:
305-313
Author(s):
Tohru Obata, Yoshio Endo, Daigo Murata, Kazuki Sakamoto and Takuma Sasaki
CIITA and the MHCII Enhanceosome in the Regulation of MHCII Expression
Journal:
Current Genomics
Volume:
4
Page:
343-363
Author(s):
S. Landmann, J.- M. Waldburger, K. Masternak, A. Muhlethaler-Mottet and W. Reith
Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1095-1126
Author(s):
Peter C. Taylor
Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1107-1113
Author(s):
Haruhiko Ogata and Toshifumi Hibi
Granulocyte Colony-stimulating Factor as the Expecting Sword for the Treatment of Severe Sepsis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1115-1120
Author(s):
Atsuo Murata
New Aspects of Cyclosporin A Mode of Action: from Gene Silencing to Gene Up-Regulation
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
205-214
Author(s):
Laurent Mascarell and Paolo Truffa-Bachi
The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer Cells
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
187-199
Author(s):
Wei-Guo Zhu and Gregory A. Otterson
Signal Transduction Inhibitors in the Treatment of Breast Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
201-216
Author(s):
Rita Nahta, Gabriel N. Hortobagyi and Francisco J. Esteva
The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
217-223
Author(s):
WenJing Liu, Anca Bulgaru, Missak Haigentz, C. A. Stein, Roman Perez-Soler and Sridhar Mani
TGF-ß / Smad Signaling in Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
197-207
Author(s):
Diana Bello-DeOcampo and Donald J. Tindall